drugset / Trial / NCT05322512
Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
NaSingle-groupOpen-labelDiagnostic
Summary
To study the normal physiological distribution of the probe 124I-EV in human body and its ability to detect overexpression of Nectin-4 in tumor lesions.
Timeline
- Start
- 2024-05-01
- Primary completion
- 2024-12-01
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | 18F-FDG | Diagnostic / imaging agent | — | — |